Nitin Goyal, MD
Neurology · Memphis, TNNPI 1922395458
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (58.5%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 22 manufacturers reported payments, led by Siemens Medical Solutions USA, Inc. at 46.0% of the total. 2025 is the largest year on record at $16,186, more than ten times the $118 reported in 2019.
Across 148 payments — averaging $171.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Siemens Medical Solutions USA, Inc.$12K
- Penumbra, Inc.$4K
- Chiesi USA, Inc.$3K
- Medtronic$2K
- Imperative Care, Inc$1K
- Stryker$883
- plus $2K from 16 others
Across 23 payments — averaging $8600.25 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Stryker$55K
- Medtronic$51K
- Microvention, Inc.$50K
- Siemens Medical Solutions USA, Inc.$23K
- Penumbra, Inc.$20K
What the payments were for
- Consulting fees$3,42514%
- Travel & lodging$14,81559%
- Food & beverage$7,07328%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Siemens Medical Solutions USA, Inc. | 15 | $11,634 |
| Penumbra, Inc. | 19 | $4,189 |
| Chiesi USA, Inc. | 1 | $3,425 |
| Medtronic | 19 | $1,530 |
| Imperative Care, Inc | 31 | $1,234 |
| Stryker | 23 | $883 |
| Rapid Medical Ltd | 11 | $563 |
| Microvention, Inc. | 6 | $398 |
| Balt USA, LLC | 2 | $233 |
| Scientia Vascular | 3 | $189 |
| Silk Road Medical, Inc. | 1 | $189 |
| Qapel Medical Inc | 2 | $132 |
| Medical Device Business Services, Inc. | 3 | $118 |
| Abbott | 2 | $117 |
| Johnson & Johnson | 3 | $113 |
| Route 92 Medical, Inc. | 1 | $110 |
| Maduro Medical, Inc. | 1 | $94 |
| Novo Nordisk | 1 | $50 |
| Inspiremd Ltd | 1 | $41 |
| Zimmer Biomet | 1 | $41 |
| AstraZeneca | 1 | $14 |
| Boston Scientific | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Artis icono floor$10,586
- KENGREAL$3,425
- Penumbra System$2,473
- Pipeline$972
- Smart Coil$949
- STENT$508
- ARTIS icono biplane$483
- ENROUTE Transcarotid Neuroprotection System$377
- ZOOM 88-T LARGE DISTAL PLATFORM$355
- TARGET$290
- SURPASS EVOLVE$290
- WEB Aneurysm Embolization System$254
- Benchmark$253
- ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter$189
- ENROUTE Transcarotid Stent$189
- ZOOM RDL RADIAL ACCESS SYSTEM, 103CM$167
- SOFIA 6F-131CM STR$134
- HydroCoil Helical$134
- TIGERTRIEVER 17 REVASCULARIZATION DEVICE$129
- COMANECI 17$129
How this compares
$25,313 in reported general payments places this provider in the 80th percentile of 361 neurology providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BrilintaTicagrelor | 18 | $12,336 |
| ClopidogrelClopidogrel Bisulfate | 38 | $481 |
| Atorvastatin Calcium | 11 | $99 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaBrilinta | $14 | $12,33618 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 361 neurology providers in Tennessee.
Other neurology in Memphis
- Lucas ElijovichMemphis$415K
- Mark LedouxMemphis$352K
- Khalid AlsherbiniMemphis$249K
- Andrei AlexandrovMemphis$225K
- Tulio BertoriniMemphis$160K
- Rozita KhaliliMemphis$91K
- Michael LevinMemphis$47K
- Michael JacewiczMemphis$33K
- James WangMemphis$27K
- Samuel HunterSpring Hill$676K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.